GPT and metabolic dysfunction-associated steatotic liver disease: After adjusting for sex, age, BMI, BP, WHR, and FBG or further adjusting for ALT, AST, AST/ALT and UA, the association between circulating MaR1 levels and the presence of NAFLD was not affected [OR = 0.958, 95% CI = 0.928–0.989, P = 0.008] or [OR = 0.957, 95% CI = 0.926–0.989, P = 0.008].